In Senate Committee·Last action 252 days ago

H.R. 747 expands fentanyl sanctions tied to Chinese entities and officials

Officially: Stop Chinese Fentanyl Act of 2025

The bill widens who can be sanctioned over synthetic opioid trafficking linked to China and adds more oversight when the President uses emergency economic powers for drug-trafficking emergencies. It also makes clear these sanctions do not cover banning imports of physical goods.

Where it stands

Sitting in Banking

No vote scheduled. Constituent contact is what moves bills out of committee.

What this bill actually does

Broadens the legal meaning of "foreign opioid trafficker" so it can cover certain Chinese companies involved in making, distributing, selling, financing, or transporting covered synthetic opioids or precursor chemicals if they do not take credible steps to stop trafficking.
Adds some senior Chinese government and political officials to the possible foreign opioid trafficker list when they have major regulatory or law-enforcement authority and they help trafficking, encourage it, or intentionally fail to act against it.
Requires U.S. officials, during their regular reviews, to consider whether the heads of four specific Chinese agencies meet the standard for being treated as foreign opioid traffickers.

↓ Why your message matters here

This bill is sitting in committee with no scheduled vote — which means a small number of constituent messages can decide whether it moves forward or quietly dies.

Where your representatives stand

Enter your ZIP to see how your senators and member of Congress have voted, sponsored, or spoken on this bill.

The debate

What people are saying about this bill

✓Arguments in support

Accountability for the CCP: Supporters believe the bill holds the Chinese Communist Party accountable for its role in the fentanyl crisis, as Chinese companies are known to export fentanyl illegally to the U.S.
Enhanced Law Enforcement: The bill aims to strengthen law enforcement's ability to block fentanyl imports, disrupting the supply chain from China and reducing the flow of drugs across the border.
Saving Lives: With fentanyl being the leading cause of overdose deaths for young Americans, supporters argue that this bill is a critical step in protecting lives, especially among the youth.

✕Arguments against

Resource Diversion: Opponents argue that the bill diverts resources from necessary health interventions, such as addiction treatment and prevention programs.
Market Incentives for Deadlier Drugs: There is concern that cracking down on fentanyl could lead to the emergence of even more potent substances, as seen with past drug restrictions.
Mass Incarceration Risks: Critics warn that the bill could exacerbate mass incarceration and racial disparities, punishing low-level users rather than major traffickers.

Where this bill is in the process

Legislative timeline

✓

Introduced

Introduced in House

—

✓

House Committee

Under House committee consideration

—

✓

House Floor Vote

Voted on by House

—

✓

Passed House

Approved by House

—

●

Senate Review

Sent to Senate for consideration

Latest: Received in the Senate and Read twice and referred to the Committee on Banking, Housing, and Urban Affairs. (9/3/2025)

SEP 3

○

Passed Both Chambers

Approved by both House and Senate

—

○

Signed into Law

Signed by the President

—

For more detail

Menu

H.R. 747 expands fentanyl sanctions tied to Chinese entities and officials

Where your representatives stand

What people are saying about this bill

Legislative timeline

Read deeper